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Take home message 
Within certain limits, missing items in the EXACT instrument can be imputed from the remaining 
answered items. 
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To the Editor 
The Exacerbations of Chronic Pulmonary Disease Tool (EXACT) is a 14-item, self-administered daily 
symptom diary designed to identify and characterise exacerbations of chronic obstructive pulmonary 
disease (COPD). It provides a reliable, valid and standardised measure of exacerbations symptoms, 
and is sensitive to changes during recovery [1]. Scores are expressed on a 100-point scale, with 
higher values indicating worse symptoms or health state. In addition, the EXACT-derived E-RS 
provides valid daily COPD symptom scores [2, 3]. Electronic administration is recommended and has 
several advantages, notably in preventing item omission [4]. However, the expense of electronic 
solutions may prove prohibitive, particularly in non-commercial studies, when a pen-and-paper 
version may be used instead. In this context, it is important to have a method to deal with missing 
items. This is yet to be established. 
In psychometrically-validated instruments with high internal consistency, such as the EXACT 
(Cronbach-α ≥0.9 [1, 5]), missing items may be imputed from the remaining answered items [6]. Used 
appropriately, this is preferable to listwise deletion of incomplete records, which reduces power and 
risks introducing bias if data are missed not at random, and to substituting values from neighbouring 
records (‘last-observation-carried-forward’ or ‘next-value-carried-backward’), as this assumes 
symptoms are in steady state, which is unlikely to hold during an exacerbation [6]. However, imputing 
items increases random error and, if items are missed systematically, may introduce bias. These 
factors limit the number and combination of items that can be imputed without excessively 
compromising reliability and accuracy. We sought to define the parameters under which this may be 
done by simulating item imputation on complete EXACT records from a recent study. 
The study was an investigator-led, multicentre, randomised, double-blind, placebo-controlled trial 
(NCT01247870; ISRCTN66148745). Its methods and results are detailed elsewhere [7]. Briefly, the 
trial tested metformin in 52 patients admitted to hospital for COPD exacerbations, primarily to 
establish its anti-hyperglycaemic effect. Secondary endpoints included symptomatic recovery, as 
determined by the EXACT. Eligible patients were aged ≥35 years, had established COPD, and had 
been admitted for an exacerbation with an expected inpatient stay ≥48 hours. Participants completed 
the EXACT on paper every evening for 1 month, including in hospital. Guidance was provided by 
investigators in person during the inpatient phase, and telephone support was available following 
discharge. 
The effect of imputing items was simulated on EXACT diary records from the first 17 participants, 
representing all participants enrolled by the time of this analysis. This dataset comprised 361 EXACT 
diary records, of which 302 (84%) were complete. In the first simulation, one randomly-selected item 
was deleted from each complete record and an imputed score substituted in its place. Imputed scores 
were calculated as the mean raw score from the remaining items, rounded to the nearest integer and 
capped at the maximum available for item being imputed. The total imputed and actual raw scores 
were transformed to a 100-point linear scale for analysis and interpretation [4]. The degree to which 
systematic error (bias) was introduced by imputation was quantified by the mean difference between 
imputed and actual scores (imputed−actual). Random error was quantified by the standard deviation 
(SD) of the difference, and 95% limits of agreement were calculated [8]. To stabilise the estimates, 
they were averaged from 500 iterations of the item-imputation simulations. The same procedure was 
adopted to evaluate the effects of imputing 2, 3, 4, 5 and 6 randomly-selected items. 
To identify items susceptible to systematic omission due to changing symptoms or setting of care, 
omission rates were compared between the inpatient and outpatient phases of the study. Those items 
with differential omission rates were subjected to further analysis using complete EXACT records from 
all 52 trial participants, systematically imputing these items on 12 representative days (days 2–10, 15, 
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20 and 28, where day 1 was defined as the day of admission). Mean difference, SD and 95% limits of 
agreement were calculated for all possible item-omission combinations for these three items. 
Overall, the mean (SD) difference between imputed and actual scores ranged from −0.06 (1.12) to 
+0.26 (4.42) points, depending on the number of items imputed. These differences, and their 95% 
limits of agreement, are illustrated in Figure 1. Items that were omitted significantly more frequently in 
the inpatient phase were item 9 (breathlessness with personal care; omitted on 5% of inpatient days 
vs. 1% of outpatient days), item 10 (breathlessness with indoor activities; 28% vs. 10%, respectively) 
and item 11 (breathlessness without outdoor activities; 31% vs. 15%, respectively) (P<0.001 in each 
case). For these items, the overall mean difference (SD; 95% limits of agreement) was −0.6 (0.8; −2.2 
to +1.1) points when any 1 item was imputed, −1.2 (1.6; −4.2 to +1.9) when any 2 items were 
imputed, and −2.0 (0.3; −6.6 to +2.8) when all three were imputed. This appeared stable over the 12 
days on which this was analysed. 
Our results suggest that, in general, imputation introduces negligible systematic bias in the total 
EXACT score, but random error increases progressively with the number of items imputed. The 
average intra-patient day-to-day variability in EXACT scores is approximately 5 points [1], and we 
considered this a reasonable benchmark against which to set the tolerance margin for imputation. In 
general, the 95% limits of agreement are within this margin provided that no more than 3 items are 
imputed. Items 9–11 represent a special case, because their omission had a systematic component. 
Imputing these items generated bias towards underestimating the actual score. To keep the 95% 
limits of agreement within the 5-point tolerance margin, no more than 2 of these items should be 
imputed. In doing this, a mean bias of −1.2 points is generated. This is relatively small in comparison 
to the effect of an exacerbation (generally at least 10 points [5, 9]), but it should be borne in mind 
Figure 1. Difference between imputed and actual EXACT scores, according to the number of items 
imputed.  
Exacerbations of Chronic Pulmonary Disease Tool (EXACT) scores are expressed on a 100-point scale, with 
higher scores indicating worse symptoms or health state. Black circles denote the mean difference between 
actual and imputed scores; error bars denote the standard deviation of the difference; and the dashed lines 
indicate 95% limits of agreement. These estimates were generated from 500 iterations of random item-
imputation simulations. Illustrative data points from one such iteration are denoted by grey spots. 
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during data interpretation. The high omission rates for items 9–11 among hospital inpatients may 
raise questions over their validity in this setting. However, while the method we have proposed can 
compensate for partial missing data, prospectively removing these items for inpatients would require a 
new validation process.  
A limitation of these simulations is that, by necessity, they were performed on complete diary records. 
One cannot know whether imputation has the same effects where the participants have themselves 
elected to omit items. The pattern of omission suggests that this might occur where participants 
consider the questions inapplicable to their present condition. For example, the patients may judge 
that quantifying breathlessness outside the home may be inapplicable whilst they are in hospital. 
Compelled to answer, these patients may have responded differently to those who answered the 
question from the outset. That said, we stressed to participants in the trial the importance of 
answering all items on every occasion. Consequently, the dataset likely includes reasonable 
representation from participants who recognised the same incongruence, but answered the question 
anyway. 
In conclusion, we recommend that missing EXACT items may be imputed from the remaining 
answered items, provided no more than 3 items are imputed in total, and no more than 2 of items 9–
11. The imputed score is calculated from the mean of the remaining item scores, rounded to the 
nearest integer and capped at the maximum score available for that item. 
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